Pancreatic Cyst Clinical Trial
Official title:
A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the Pancreas
A multicentre phase II study to determine the safety and efficacy of EUS-guided nCLE in patients with suspected cystic tumours of the pancreas in whom endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is clinically indicated. Patients will be recruited sequentially to undergo nCLE as part of their routine diagnostic evaluation, followed by standard surveillance. This part of the study will recruit 60 patients.
A multicentre phase II study to determine the safety and efficacy of EUS-guided nCLE in
patients with suspected cystic tumours of the pancreas in whom endoscopic ultrasound-guided
fine needle aspiration (EUS-FNA) is clinically indicated. Patients will be recruited
sequentially to undergo nCLE as part of their routine diagnostic evaluation, followed by
standard surveillance. This part of the study will recruit 60 patients. The study also
includes a feasibility study to evaluate the role of intraoperative nCLE in the diagnosis and
staging of pancreatic tumours. This part of the study will recruit a further 20 patients.
Primary endpoint:
Assess the diagnostic performance of the Cellvizio nCLE system in the characterization of
pancreatic cysts, compared to standard diagnostic modalities.
Secondary endpoints:
- Assess the safety and efficacy of EUS-nCLE.
- Assess the impact of the Cellvizio nCLE system on the management of patients with
pancreatic cysts.
- Develop and validate interpretation criteria for nCLE in the pancreas.
- Assess the diagnostic performance of nCLE in characterising and staging pancreatic
tumours intraoperatively.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05572788 -
Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts
|
N/A | |
| Not yet recruiting |
NCT06320990 -
Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection
|
Phase 1 | |
| Completed |
NCT01770405 -
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
|
N/A | |
| Completed |
NCT01643460 -
Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts
|
N/A | |
| Recruiting |
NCT03260842 -
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
|
||
| Recruiting |
NCT04291651 -
UCSF PANC Cyst Registry
|
||
| Recruiting |
NCT05692596 -
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
|
||
| Recruiting |
NCT03334708 -
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
|
||
| Recruiting |
NCT04140435 -
EUS-guided Through-the-needle Microforceps Biopsy Outcomes
|
||
| Terminated |
NCT00550108 -
Management of Incidentally Discovered Pancreatic Cysts
|
Phase 3 | |
| Recruiting |
NCT03492151 -
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
|
||
| Completed |
NCT03169842 -
Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts
|
N/A | |
| Recruiting |
NCT04404101 -
Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies
|
N/A | |
| Recruiting |
NCT06305728 -
A Study of Early Cancer Detection in People at High Risk of Developing Pancreatic Ductal Adenocarcinoma (PDAC)
|
||
| Recruiting |
NCT06340620 -
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
|
N/A | |
| Recruiting |
NCT02343692 -
A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas
|
N/A | |
| Recruiting |
NCT02775461 -
Pancreas Registry and High Risk Registry
|
||
| Active, not recruiting |
NCT01563133 -
Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas
|
N/A | |
| Completed |
NCT00222898 -
Cancer Detection in Pancreatic Cysts
|
N/A | |
| Not yet recruiting |
NCT06276764 -
The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
|